Mamisan Ointment Recalled: Kids Shouldn't Have Access to Lidocaine
Plantimex has issued a recall for more than 50,000 jars of Mamisan Pain Relieving Topical Ointment after discovering that the product’s packaging ignored federal requirements for child‑resistant lids
What Went Wrong
The ointment itself is fine. The lid? Not so much.
Instead of the mandated child‑resistant closure, the jars feature a basic twist‑off top — the kind that practically begs to be opened by the smallest, most determined humans in your household.
Under the Poison Prevention Packaging Act, lidocaine products must be secured behind a lid that requires at least a moment of adult thought. This one requires… wrist rotation.
The Product in Question
- Bright orange jar
- White continuous-thread lid
- Mamisan trademark on top
- UPC 860006498115
- Sold at Walmart, Target, and Target.com from April 2024 to October 2025
If you’ve got one, congratulations: you need to get rid of it.
The Hazard
Lidocaine is not a snack.
It is not a toy.
It is not something you want a child ingesting under any circumstances.
Thankfully, no injuries have been reported. Let’s keep it that way.
What You Should Do
Plantimex will send you a free child‑resistant replacement lid. Until then:
- Hide the jar like it’s your tax return
- Keep it far from tiny hands with big ambitions
- Use it only after the new lid is installed
Contact Plantimex at 855‑752‑6869, email customercare@plantimexusa.com with “RECALL” in the subject line, or visit their website for details.
The Takeaway
This recall is a reminder that packaging isn’t decorative. It’s not optional. It’s not a vibe. It’s a literal safety barrier between a household product and a medical emergency.
A pain‑relief ointment should soothe muscles — not test your emergency‑room copay.
# # #